Multidisciplinary Analysis of Cyclophilin A Function in Human Breast Cancer
Abstract
The ongoing purpose of this work is to examine the effects of altered cyclophilin A (CypA) levels and activity on the prolactin receptor (PRLr) associated signaling and its role in breast cancer development and/or progression. To this end, we have further demonstrated that siRNA-mediated CypA knockdown or the use of CypA inhibitors such as cyclosphorine A (CsA) analogs-CsD and CsH significantly abrogated the PRLr signaling and breast cancer cell growth in vitro. In addition, by using a novel antibody phage display technology, we have developed several synthetic antibodies, which exhibit nanomolar affinities for the CypA. Experiments are currently underway to test these potential synthetic antibodies in vitro and in vivo.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2010
- Accession Number
- ADA525263
Entities
People
- Jiamao Zheng
Organizations
- Northwestern University